Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 436.00 (2025-05-23)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Vertex Pharmaceuticals Incorporated (VRTX) had Net Income of $646.30M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$2.77B
Net Income
$646.30M
$363.00M
$2.41B
$2.14B
$630.10M
$100.30M
$730.40M
$730.40M
$646.30M
$646.30M
$646.30M
$646.30M
$630.10M
$678.50M
256.90M
259.50M
$2.52
$2.49
Balance Sheet Financials
$10.01B
$1.30B
$12.87B
$22.88B
$3.78B
$111.40M
$2.60B
$6.38B
$16.50B
$14.97B
$16.50B
256.97M
Cash Flow Statement Financials
$818.90M
$-55.80M
$-680.40M
$4.57B
$4.69B
$113.20M
$166.10M
--
--
Fundamental Metrics & Ratios
2.65
--
--
0.01
0.01
86.90%
22.75%
22.75%
--
26.37%
23.33%
$778.20M
--
--
--
0.12
0.27
1.53
58.65
3.92%
4.32%
2.82%
3.89%
$64.20
$3.00
$3.16